AzTrials
AzTrials

Postoperative RecoveryTRANSATNCT05450172

Impact of Postoperative Transitional Pain on Recovery After Thoracic Surgery

An observational study of Postoperative Recovery, run by University Hospital, Angers at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Postoperative transitional pain corresponds to the pain occuring between acute postoperative pain and chronic postsurgical pain (defined as pain persisting for at least 3 months after surgery). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Postoperative Recovery
What is being tested?
QoR-15 questionnaire
How many people
204 participants
Where
1 siteFrance
Study dates
10 Oct 2022to 10 Jun 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients scheduled for thoracic surgery (thoracotomy or video-assisted thoracic surgery or surgery for thoracic outlet syndrome).

Who may be able to join

  • adult patients
  • patients scheduled for thoracic surgery (thoracotomy or video-assisted thoracic surgery or surgery for thoracic outlet syndrome)
  • patients who do not object to the study

Who cannot join

  • patients non francophone
  • emergency surgery or revision surgery
  • patients already included in the study during the previous 6 months

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU

    Angers, 49933

Other trials in France

About this study

Postoperative transitional pain corresponds to the pain occuring between acute postoperative pain and chronic postsurgical pain (defined as pain persisting for at least 3 months after surgery). We hypothesized that both trajectory and neuropathic component of transitional pain may influence the quality of recovery after thoracic surgery. To test this, we designed an observational study to identify risk factors for incomplete recovery assessed through the QoR-15 questionnaire.

Being tested
QoR-15 questionnaire
Keywords
Postoperative transitional pain, postoperative pain trajectory, postoperative neuropathic pain, thoracic surgery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QoR-15 questionnaireOther

    Also called DN4 questionnaire

    The QoR-15 is a 15-item questionnaire on postoperative quality of recovery. The DN4 is a 10-item questionnaire on neuropathic pain. Both questionnaires will be given to the patients preoperatively, on postoperative days 2 and 3, and 1, 3 and 6 months after surgery.

Study groups in NCT05450172
Study groupRoleWhat they receive
Consecutive patients scheduled for thoracic surgeryNot described
Receives: Other: QoR-15 questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Impact of pain trajectory and neuropathic component of pain on quality of recovery.

    An incomplete recovery will be defined as a postoperative QoR-15 score of at least 8 points lower than the preoperative QoR-15 value. The association between both trajectory and neuropathic component of postoperative transitional pain and incomplete recovery will be evaluated.

    Measured: 3 months after surgery.

Secondary outcomes (5)
  1. Description of trajectory and neuropathic component of postoperative transitional pain.

    To describe the trajectory and neuropathic component of postoperative transitional pain according to QoR-15 and DN4 successive values.

    Measured: Between postoperative day 2 and 3 months after surgery.

  2. Impact of the type of surgery on quality of recovery.

    To assess the impact of thoracotomy or video-assisted thoracic on quality of recovery.

    Measured: 3 months after surgery.

  3. Impact of pain trajectory, neuropathic component of pain and type of surgery on chronic postsurgical pain prevalence.

    To assess the impact pain trajectory, neuropathic component of pain and type of surgery on chronic postsurgical pain prevalence.

    Measured: 3 and 6 months after surgery.

  4. Predictive accuracy of neuropathic pain trajectory on incomplete recovery and chronic postsurgical pain prevalence.

    To assess the predictive accuracy of neuropathic pain trajectory on incomplete recovery and chronic postsurgical pain prevalence.

    Measured: 3 and 6 months after surgery.

  5. Correlation between neuropathic componente of chronic postsurgical pain and quality of recovery.

    To assess the correlation between neuropathic componente of chronic postsurgical pain and quality of recovery.

    Measured: 3 and 6 months after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2022
  2. Study start10 Oct 2022
  3. Primary completion10 Mar 2024
  4. Study completion10 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
204 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05450172
Sponsor's protocol ID
49RC22_0203
Acronym
TRANSAT
Status last verified
Dec 2025
First submitted
5 Jul 2022
Last updated
30 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Recovery, run by University Hospital, Angers at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Impact of pain trajectory and neuropathic component of pain on quality of recovery. (time frame: 3 months after surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in